Genflow Biosciences (GENF) Competitors GBX 1.76 +0.01 (+0.34%) (As of 07:22 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors GENF vs. OKYO, OBI, HEMO, AOR, RLM, NSCI, OPTI, ONC, SNG, and BVXShould you be buying Genflow Biosciences stock or one of its competitors? The main competitors of Genflow Biosciences include OKYO Pharma (OKYO), Ondine Biomedical (OBI), Hemogenyx Pharmaceuticals (HEMO), AorTech International (AOR), Realm Therapeutics (RLM), NetScientific (NSCI), OptiBiotix Health (OPTI), Oncimmune (ONC), Synairgen (SNG), and BiVictriX Therapeutics (BVX). These companies are all part of the "biotechnology" industry. Genflow Biosciences vs. OKYO Pharma Ondine Biomedical Hemogenyx Pharmaceuticals AorTech International Realm Therapeutics NetScientific OptiBiotix Health Oncimmune Synairgen BiVictriX Therapeutics OKYO Pharma (LON:OKYO) and Genflow Biosciences (LON:GENF) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, community ranking, dividends, valuation, earnings, media sentiment, institutional ownership and profitability. Which has more risk and volatility, OKYO or GENF? OKYO Pharma has a beta of -0.06, indicating that its stock price is 106% less volatile than the S&P 500. Comparatively, Genflow Biosciences has a beta of 2.37, indicating that its stock price is 137% more volatile than the S&P 500. Which has better earnings & valuation, OKYO or GENF? Genflow Biosciences is trading at a lower price-to-earnings ratio than OKYO Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOKYO PharmaN/AN/A-£6.70M-£0.01-140.00Genflow BiosciencesN/AN/A-£1.53M-£0.01-175.00 Does the media refer more to OKYO or GENF? In the previous week, OKYO Pharma's average media sentiment score of 0.00 equaled Genflow Biosciences'average media sentiment score. Company Overall Sentiment OKYO Pharma Neutral Genflow Biosciences Neutral Does the MarketBeat Community prefer OKYO or GENF? OKYO Pharma received 7 more outperform votes than Genflow Biosciences when rated by MarketBeat users. CompanyUnderperformOutperformOKYO PharmaOutperform Votes763.64% Underperform Votes436.36% Genflow BiosciencesN/AN/A Do insiders and institutionals hold more shares of OKYO or GENF? 9.2% of Genflow Biosciences shares are held by institutional investors. 31.9% of OKYO Pharma shares are held by company insiders. Comparatively, 64.2% of Genflow Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is OKYO or GENF more profitable? OKYO Pharma has a net margin of 0.00% compared to Genflow Biosciences' net margin of -256.07%. Genflow Biosciences' return on equity of -118.88% beat OKYO Pharma's return on equity.Company Net Margins Return on Equity Return on Assets OKYO PharmaN/A -397.13% -154.72% Genflow Biosciences -256.07%-118.88%-58.66% SummaryGenflow Biosciences beats OKYO Pharma on 6 of the 9 factors compared between the two stocks. Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Get Genflow Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GENF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GENF vs. The Competition Export to ExcelMetricGenflow BiosciencesBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£6.12M£160.84M£5.06B£1.48BDividend YieldN/A3.31%5.18%11.75%P/E Ratio-175.00298.44126.311,622.87Price / SalesN/A16,237.521,178.74232,521.30Price / Cash3.0011.5033.8631.75Price / BookN/A7.364.682.68Net Income-£1.53M-£19.24M£119.54M£161.21M7 Day Performance-3.05%-0.31%-1.83%-0.60%1 Month Performance-2.78%8.63%-3.60%7.85%1 Year Performance-2.78%27.00%31.91%19.06% Genflow Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GENFGenflow BiosciencesN/AGBX 1.76+0.3%N/A-8.2%£6.14MN/A-175.605Gap UpOKYOOKYO PharmaN/AGBX 1.40-24.3%N/AN/A£23.24MN/A-140.007Gap DownOBIOndine BiomedicalN/AGBX 8.13flatN/A-18.4%£22.53M£1.63M-270.83N/AHEMOHemogenyx PharmaceuticalsN/AGBX 1.51+5.3%N/A-42.6%£20.25MN/A-143.5014Gap DownAORAorTech InternationalN/AGBX 123.50-2.4%N/AN/A£19.99M£539,000.00-33.383RLMRealm TherapeuticsN/AGBX 11.50flatN/A+0.0%£13.41M£501,919.00-0.66N/ANSCINetScientificN/AGBX 53.50flatN/A-18.2%£12.81M£1.45M-486.3626OPTIOptiBiotix HealthN/AGBX 12.80-1.5%N/A-52.3%£12.54M£1.26M-422.171Gap DownONCOncimmuneN/AGBX 15.14+0.3%N/A-33.2%£11.23M£1.21M-505.0052Positive NewsHigh Trading VolumeSNGSynairgenN/AGBX 4.35-5.3%N/A-26.6%£8.75M£79,000.00-144.8734Gap DownBVXBiVictriX TherapeuticsN/AGBX 10+17.6%N/A-9.1%£8.25MN/A-250.0017Gap UpHigh Trading Volume Related Companies and Tools Related Companies OKYO Competitors OBI Competitors HEMO Competitors AOR Competitors RLM Competitors NSCI Competitors OPTI Competitors ONC Competitors SNG Competitors BVX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:GENF) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genflow Biosciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Genflow Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
